Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Crossover On-Road Driving Study Assessing the Effect of JZP-110 on Driving Performance in Subjects with Excessive Sleepiness Due to Narcolepsy

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 13 Dec 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

10 Dec 2022 Results of pooled analysis from two phase 2 studies (NCT02806895, EudraCT 2015-003930-28, NCT02806908, EudraCT 2015-003931-36) published in the Neurology and Therapy
22 Apr 2021 Primary endpoint (Standard Deviation of Lateral Position (SDLP) at 2 Hours Post-dose (Approximately at Tmax) has been met according to the results presented at the 73rd Annual Meeting of the American Academy of Neurology
22 Apr 2021 Results assessing the effects of solriamfetol on on-road driving performance in participants with narcolepsy presented at the 73rd Annual Meeting of the American Academy of Neurology

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com